Predictors for doxorubicin-induced hematological toxicity and its association with outcome in advanced soft tissue sarcoma patients; a retrospective analysis of the EORTC-soft tissue and bone sarcoma group database

Stefan SleijferDepartment of Medical Oncology, Erasmus MC Cancer Institute, Rotterdam, The Netherlands; Correspondence[email protected]

Elisa RizzoStatistics Department, European Organisation for Research and Treatment of Cancer (EORTC), Brussels, Belgium;

Saskia LitièreStatistics Department, European Organisation for Research and Treatment of Cancer (EORTC), Brussels, Belgium;

Ron H. J. MathijssenDepartment of Medical Oncology, Erasmus MC Cancer Institute, Rotterdam, The Netherlands;

Ian Robert JudsonCancer Research UK, Centre for Cancer Therapeutics, Sutton, United Kingdom;

Hans GelderblomDepartment of Medical Oncology, Leiden University Medical Center, Leiden, The Netherlands;

Winette T. A. Van Der GraafDepartment of Medical Oncology, Radboudumc, Nijmegen, The Netherlands; ;The Institute of Cancer Research, London, UK;

Alessandro GronchiFondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy

Related Research Data